0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Reduction of Central Epinephrine Concentrations Is Consistent with the Continued Occurrence of Ovulation in Rats Treated with an Inhibitor (LY 134046) of Phenylethanolamine N-Methyltransferase

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Groups of 4-day cyclic rats were injected (i.p.) with LY 134046 (50 mg/kg), a central inhibitor of phenylethanolamine N-methyltransferase, or saline at 09.00, 13.00 and 19.00 h on the day of proestrus. The incidence of ovulation was examined the following estrous morning. There was no difference in the number of ova in drug-treated animals compared to saline-treated controls. In other groups of 4-day cyclic rats, LY 134046 or saline was injected daily at 10.00 h for 5 consecutive days from proestrus to proestrus inclusive. The animals were decapitated the following day and ova were counted. Epinephrine concentrations were determined by radioenzymatic assay in the mediobasal hypothaiamus (MBH) and the medial preoptic area (MPOA). All saline-treated controls and 10/14 of the drug-treated animals had ovulated, while epinephrine concentrations in the MBH and MPOA had been reduced by 95.8 and 94.7%, respectively, compared to saline-treated controls. These experiments suggest that a significant surge of luteinizing hormone occurs to initiate ovulation even after a severe reduction in central epinephrine concentration has taken place.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1985
          1985
          28 March 2008
          : 41
          : 5
          : 432-436
          Affiliations
          Department of Human Anatomy, University of Oxford, England
          Article
          124214 Neuroendocrinology 1985;41:432–436
          10.1159/000124214
          3903538
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Categories
          Original Paper

          Comments

          Comment on this article